Liquid chromatographic determination of propoxyphene and norpropoxyphene in plasma and breast milk.
A sensitive and specific high-performance liquid chromatographic (HPLC) procedure was developed for determination of propoxyphene and norpropoxyphene in plasma and breast milk. The compounds were isolated from the biological specimen by extraction, the organic phase was evaporated to dryness, and the residue was redissolved in mobile phase [acetonitrile: 0.002 M H2SO4 (1:1)]. The resultant solution was then injected into an HPLC system utilizing a C18 reversed-phase analytical column and a variable-wavelength detector set at 205 nm. Under these conditions the method has a sensitivity of 20 ng/mL using 1 mL of plasma or milk. The within-run coefficient of variation for both compounds varied between 6.2 and 8.9% within the concentration range tested. Applicability of the method was demonstrated in a nursing mother who received multiple oral doses of propoxyphene.
D002851:Chromatography, High Pressure Liquid; D011431:Dextropropoxyphene / Q000031:analogs & derivatives* / Q000032:analysis* / Q000097:blood; D005260:Female; D006801:Humans; D008895:Milk, Human / Q000032:analysis*; D013056:Spectrophotometry, Ultraviolet
C002756:norpropoxyphene; D011431:Dextropropoxyphene